Our findings have been corroborated in numerous studies, i.e., that elevated levels of MMP-9, particularly in the acute phase of stroke, are associated with worse outcomes, and a sustained decrease in MMP-9 levels following several days of treatment is indicative of a favorable prognosis [10,22]. This evidence concerns the gene MMP9 and stroke disorder.